Reuters logo
BRIEF-Sino Biopharmaceutical posts HY revenue of about RMB7,482.86 mln
August 21, 2017 / 10:36 AM / a month ago

BRIEF-Sino Biopharmaceutical posts HY revenue of about RMB7,482.86 mln

Aug 21 (Reuters) - Sino Biopharmaceutical Ltd

* HY revenue was approximately RMB7,482.86 million, an increase of approximately 10.6 percent

* Board of directors of company declared payment of a second quarterly dividend of HK2 cents per share

* Before accounting for unrealized fair value gains & losses of equity investments & financial assets, HY net profit about RMB1,076.34 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below